We provide technical solutions to the human blood plasma fractionation industry, meeting the most stringent requirements of the industry by concomitantly integrating technology, process knowledge and quality systems and training. Our interdisciplinary approach and vast knowledge of the particular features of plasma fractionation make us the preferred partner for fractionation facility/technology projects.
Precipitations, chromatographic separations, membrane filtration, viral inactivation techniques (pasteurization, solvent/detergent, pH-treatment, etc.), sterile filtration, aseptic filling, freeze drying.
The Onix Process: the perfect combination of chromatography and Cohn Fractionation stands out for its industrial scalability, cost-effectiveness, robust product quality, operational flexibility, and strong business risk mitigation features compared to competing alternative plasma extraction and purification technologies.
Plasmapool
Recovered and Source Plasma
Cryoprecipitate
Factor VIII
Other coagulation factors
Paste II
Immunoglobulin G
Paste V
Human Albumin
PlasmaPharm licenses the manufacturing technology and nonexclusive market authorizations for all listed products. We support the dossiers with eCTD documentation, which needs to be adapted for the target country; registration by the licensee.
Immunoglobulin Products
Subcutaneous IG 16%
Intravenous IG 5%, 10%
Anti-RhD
Anti-HAV
Anti-Tetanus
Anti-CMV
Anti-Measles
Anti-Rabies
Clotting Products
Factor VIII
Factor IX
PPSB
Fibrinogen
Albumin Products
Albumin 4%, 5%
Albumin 20%, 25%